Detection method for biological activity of liraglutide

A biologically active, liraglutide technology, applied in biological testing, chemiluminescence/bioluminescence, analysis by chemical reaction of materials, etc., can solve problems such as harm to the human body, and achieve good accuracy and repeatability , the effect of the simple method

Active Publication Date: 2014-06-25
HANGZHOU JIUYUAN GENE ENG +1
View PDF6 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Since young hamster kidney cells expressing the human pancreatic GLP-1 receptor are difficult to obtain; and the scintillation proximity assay uses ...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Detection method for biological activity of liraglutide
  • Detection method for biological activity of liraglutide
  • Detection method for biological activity of liraglutide

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] (1) Take RIN-m5F cells in good growth state, spread them in white flat-bottomed 96-well cell culture plates, 7000 cells / well, and place them in a 5% carbon dioxide incubator at 37°C for static culture for three days.

[0048] (2) Weigh some liraglutide raw powder, dissolve it with 10mM disodium hydrogen phosphate solution (pH8.2), and heat it in a water bath at 80°C for 47 hours. Then weigh some liraglutide raw powder and dissolve it with 10mM disodium hydrogen phosphate solution (pH8.2). The heat-treated liraglutide solution, the untreated liraglutide solution and the original preparation of liraglutide were pre-diluted respectively to prepare a dilution solution with a concentration of 0.006 mg / ml. Then divide into two groups to prepare the concentration gradient, and set 7 concentration points. Group 1 was the original liraglutide preparation and untreated liraglutide solution. Group 2 was heat-treated liraglutide solution and untreated liraglutide solution. T...

Embodiment 2

[0053] (1) Take RIN-m5F cells in a good growth state, spread them in a white flat-bottomed 96-well cell culture plate, 7000 cells / well, and place them in a 37°C, 5% carbon dioxide incubator for static culture for three days.

[0054] (2) Weigh some liraglutide test substance and reference substance, and dissolve them with 10mM disodium hydrogen phosphate solution (pH8.2). According to the weighing amount, the test sample was pre-diluted 156 times, the reference substance was pre-diluted 135 times, the same concentration gradient was prepared, the concentration was 0.006mg / ml, 8 concentration points were set, and the dilution times were 32 times, 64 times, 128 times Times, 256 times, 1280 times, 6400 times, 32000 times, 800,000 times.

[0055] (3) Aspirate the supernatant in the cell wells in step (1), add a concentration gradient of liraglutide to stimulate the cells, and place the cell plate at 37°C for 5 minutes.

[0056] (4) Use the cAMP-dependent protein kinase A acti...

Embodiment 3

[0059] Experimental procedure is identical with embodiment 2. Known that the activity of the test product is 39,500 U / ml, the biological activity of the test product was tested five times, and the test results are shown in Table 1. The recovery rate of the test results ranged from 70% to 120%, the average value was 102%, and the RSD was 20%, which indicated that the accuracy and repeatability of the method were good.

[0060] Table 1 Verification of accuracy and repeatability

[0061]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

According to the invention, the change of the level of 3',5'-cyclic adenosine monophosphate (cAMP) is taken as a detection index and a cAMP-depending type protein kinase A active analysis method is used for determining the biological activity of liraglutide. Rat insulinoma cells RIN-m5F are cultivated and a diluted liraglutide comparison product solution and a diluted test solution are added; a kit is used for detecting the change of the level of the cAMP in stimulated cells; a super-sensitive chemiluminiscence detection module of a multifunctional enzyme linked immunosorbent assay is used for reading a relative chemiluminiscence unit (RLU) and statistical software is used for fitting experimental data; the biological activity of a product to be detected is calculated by a formula. The method can be used for simply, conveniently, rapidly and accurately detecting the change of the biological activity of the liraglutide; the accuracy and the repeatability accord with the requirements of a biological activity determination method of biological products.

Description

technical field [0001] The invention belongs to the field of biotechnology, and in particular relates to a method for measuring the biological activity of liraglutide. Background of the invention [0002] Diabetes is an increasingly serious threat to human health worldwide. Glucagon-like peptide-1 (GLP-1) is a polypeptide hormone secreted by intestinal L cells, which has the functions of promoting insulin secretion and promoting the proliferation and differentiation of pancreatic β cells. It exerts its hypoglycemic effect by stimulating insulin secretion, inhibiting glucagon secretion, and inhibiting gastric emptying. Since its stimulation of insulin is glucose-dependent, it does not cause symptoms of hypoglycemia. [0003] Natural GLP-1 is not suitable for clinical application due to its short half-life (only 1-2 minutes). Liraglutide has 97% homology with GLP-1 and is clinically used to control blood sugar in adults with type 2 diabetes. The difference between its mole...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G01N33/68G01N21/76
CPCG01N21/76G01N33/68
Inventor 卢旻衎周亮曹阳戎亚雯吉鹏飞马国昌
Owner HANGZHOU JIUYUAN GENE ENG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products